Owners and management
CVR: 46363884
Not available
Ditte Malling Maymann (50-66,65%), Per Malling Maymann (50-66,65%)
CVR · view owners
Ditte Malling Maymann
CVR · view management
Active
Founded 23 March 2026
CVR · view overview
No headcount reported
Name registered: Dexaklinik Nord ApS
CVR · 23/03/2026
View the full event history
Dexaklinik Nord ApS is a Danish company of the type Anpartsselskab based in Allerød, founded in 2026. The company is registered under the industry Billeddiagnostiske undersøgelser og medicinske laboratorieaktiviteter. The management consists of Ditte Malling Maymann. The company is owned by Ditte Malling Maymann and Per Malling Maymann.
Selskabets formål er at tilbyde sundhedsrelaterede scanninger og målinger, herunder DEXA scanninger til vurdering af knoglesundhed og kropskomposition, samt relateret rådgivning og sundhedsydelser.
No annual financial figures are available for this company.
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningThe CVR number of Dexaklinik Nord ApS is 46363884.
Dexaklinik Nord ApS is owned by Ditte Malling Maymann and Per Malling Maymann.
The management of Dexaklinik Nord ApS consists of Ditte Malling Maymann.
Dexaklinik Nord ApS was founded on 23 March 2026.
Dexaklinik Nord ApS is registered under the industry Billeddiagnostiske undersøgelser og medicinske laboratorieaktiviteter (industry code 869100).
Dexaklinik Nord ApS is located at Torvestrædet 3 1., 3450 Allerød.
Claim this page to add your logo and social links. Free to get started.
As of March 23, 2026, Ditte Malling Maymann is registered as adm. dir. of Dexaklinik Nord ApS.
As of March 23, 2026, Ditte Malling Maymann is registered as an owner of Dexaklinik Nord ApS with an ownership share of 50%.
As of March 23, 2026, Per Malling Maymann is registered as an owner of Dexaklinik Nord ApS with an ownership share of 50%.
Dexaklinik Nord ApS was founded on March 23, 2026.
